Skip to main content

Advertisement

Log in

Bacterial spectrum of spontaneously ruptured otitis media in the era of pneumococcal conjugate vaccination in Germany

  • Original Article
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Otitis media is a common pediatric disease and the main reason for antibiotic prescription in children. Before implementation of routine childhood pneumococcal vaccination in Germany, serotypes contained in the seven-valent pneumococcal conjugate vaccine (PCV) were among the most frequent pneumococcal serotypes responsible for acute otitis media (AOM). This report describes the first 3 years of a prospective, multicenter, epidemiological cross-sectional study examining the bacteriology of middle ear fluids (MEF) and nasopharyngeal swabs (NPS) of children 2 months to 5 years of age with spontaneously perforated AOM in the era of routine pneumococcal vaccination. MEF was obtained from 963 subjects; NPS from 877. Reported case numbers steeply decreased over the three study years even though the recruiting base remained the same. Among subjects with relevant bacterial growth in their MEF swabs, 113 (11.7 %) had Streptococcus pyogenes, 97 (10.1 %) Staphylococcus aureus, 88 (9.1 %) Streptococcus pneumoniae, 63 (6.5 %) Haemophilus influenzae, and 8 (0.8 %) Moraxella catarrhalis. S. pneumoniae isolates decreased from 41 (9.3 %) in year 1 to 12 (5.7 %) in year 3 (p = 0.128). PCV7 serotypes accounted for only 7.9 % (n = 7) of isolated pneumococci. Of the 877 subjects with NPS cultures, 465 (53.0 %) carried S. pneumoniae, 314 (35.8 %) H. influenzae, 292 (33.3 %) M. catarrhalis, and 110 (12.5 %) S. pyogenes; 79.4 % (n = 765) of the children were vaccinated with at least one dose of PCV. Carriage of pneumococci was slightly lower in vaccinated (47.8 %) than in unvaccinated (52.7 %) children (p = 0.254). PCV7 serotypes were carried by 9.6 % of unvaccinated children but by only 4.2 % of vaccinated children, resulting in a 56.3 % vaccine effectiveness.

Conclusions: Following universal PCV7 immunization, a clear epidemiological impact of pneumococcal conjugate vaccination was observed as PCV7 serotypes have almost disappeared among AOM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

AOM:

Acute otitis media

GAS:

Group A Streptococcus

IPD:

Invasive pneumococcal disease

MEF:

Middle ear fluid

NIP:

National immunization program

NIPD:

Noninvasive pneumococcal disease

NPS:

Nasopharyngeal swab

NT-H. influenzae :

Nontypeable Haemophilus influenzae

PCV:

Pneumococcal conjugate vaccine

PNSP:

Penicillin nonsusceptible Streptococcus pneumoniae

References

  1. (STIKO) S (2006) Empfehlungen der Ständigen Impfkommission (STIKO) am RKI (Stand Juli 2006):Begründungen zur allgemeinen Empfehlung der Impfung gegen Pneumokokken- und Meningokokken im Säuglings- und Kindesalter. Epidemiol Bull:255–260

  2. (STIKO) S (2009) Mitteilung der STIKO zur Impfung gegen invasive Pneumokokken-Infektionen bei Kindern unter 24 Monaten, bei denen die Impfserie mit dem konjugierten 7-valenten Impfstoff begonnen wurde. Epidemiol Bull 49:507

    Google Scholar 

  3. Adam D (2002) Global antibiotic resistance in Streptococcus pneumoniae. J Antimicrob Chemother 50(Suppl 1):1–5

    Article  CAS  PubMed  Google Scholar 

  4. American Academy of Family Physicians, American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics Subcommittee on Otitis Media with Effusion (2004) Otitis media with effusion. Pediatrics 113:1412–1429

    Article  Google Scholar 

  5. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, Malinoski F, Madore D, Chang I, Kohberger R, Watson W, Austrian R, Edwards K (2000) Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 19:187–195

    Article  CAS  PubMed  Google Scholar 

  6. Block SL, Hedrick J, Harrison CJ, Tyler R, Smith A, Findlay R, Keegan E (2002) Pneumococcal serotypes from acute otitis media in rural Kentucky. Pediatr Infect Dis J 21:859–865

    Article  PubMed  Google Scholar 

  7. Bluestone CD, Klein JO (1995) Otitis media in infants and children. Philadelphia

  8. Bogaert D, Hermans PW, Adrian PV, Rumke HC, de Groot R (2004) Pneumococcal vaccines: an update on current strategies. Vaccine 22:2209–2220

    Article  CAS  PubMed  Google Scholar 

  9. Broome CV, Facklam RR, Fraser DW (1980) Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med 303:549–552

    Article  CAS  PubMed  Google Scholar 

  10. Butler JC, Breiman RF, Lipman HB, Hofmann J, Facklam RR (1995) Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978–1994: implications for development of a conjugate vaccine. J Infect Dis 171:885–889

    Article  CAS  PubMed  Google Scholar 

  11. Chen YY, Yao SM, Chou CY, Chang YC, Shen PW, Huang CT, Su HP, Li SY (2006) Surveillance of invasive Streptococcus pneumoniae in Taiwan, 2002–2003. J Med Microbiol 55:1109–1114

    Article  CAS  PubMed  Google Scholar 

  12. Choi EH, Kim SH, Eun BW, Kim SJ, Kim NH, Lee J, Lee HJ (2008) Streptococcus pneumoniae Serotype 19A in children, South Korea. Emerg Infect Dis 14:275–281

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Cohen R, Levy C, Thollot F, de La Rocque F, Koskas M, Bonnet E, Fritzell B, Varon E (2007) Pneumococcal conjugate vaccine does not influence Staphylococcus aureus carriage in young children with acute otitis media. Clin Infect Dis 45:1583–1587

    Article  PubMed  Google Scholar 

  14. Dagan R, Fraser D (2000) Conjugate pneumococcal vaccine and antibiotic-resistant Streptococcus pneumoniae: herd immmunity and reduction of otitis morbidity [in process citation]. Pediatr Infect Dis J 19:S79–S87, discussion S88

    Article  CAS  PubMed  Google Scholar 

  15. Dagan R, Givon-Lavi N, Leibovitz E, Greenberg D, Porat N (2009) Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population. J Infect Dis 199:776–785

    Article  CAS  PubMed  Google Scholar 

  16. Diel M, Laurenz M, Krause K, Sprenger R, Busse A (2013) Impact of pneumococcal conjugate vaccines on acute otitis media among children in Germany. Paper presented at European Society for Peadiatric Infectious Diseases (ESPID). Milan, Italy, 31.05.2013

  17. Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, Takala A, Käyhty H, Karma P, Kohberger R, Siber G, Mäkelä PH (2001) Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344:403–409

    Article  CAS  PubMed  Google Scholar 

  18. Fenoll A, Granizo JJ, Aguilar L, Gimenez MJ, Aragoneses-Fenoll L, Hanquet G, Casal J, Tarrago D (2009) Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J Clin Microbiol 47:1012–1020

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Fireman B, Black SB, Shinefield HR, Lee J, Lewis E, Ray P (2003) Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J 22:10–16

    Article  PubMed  Google Scholar 

  20. Fletcher MA, Fritzell B (2007) Brief review of the clinical effectiveness of PREVENAR against otitis media. Vaccine 25:2507–2512

    Article  CAS  PubMed  Google Scholar 

  21. Imöhl M, Reinert RR, Ocklenburg C, van der Linden M (2010) Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003–2007. FEMS Immunol Med Microbiol 58:389–396

    PubMed  Google Scholar 

  22. Imöhl M, Reinert RR, van der Linden M (2010) Temporal variations among invasive pneumococcal disease serotypes in children and adults in Germany (1992–2008). Int J Microbiol 2010:874189

    Article  PubMed Central  PubMed  Google Scholar 

  23. Imöhl M, Reinert RR, van der Linden M (2010) Serotype-specific penicillin resistance of Streptococcus pneumoniae in Germany from 1992 to 2008. Int J Med Microbiol 300:324–330

    Article  PubMed  Google Scholar 

  24. Marchisio P, Bianchini S, Baggi E, Fattizzo M, Galeone C, Torretta S, Principi N, Esposito S (2013) A retrospective evaluation of microbiology of acute otitis media complicated by spontaneous otorrhea in children living in Milan, Italy. Infection 41:629–635

    Article  CAS  PubMed  Google Scholar 

  25. Obaro SK, Adegbola RA, Banya WA, Greenwood BM (1996) Carriage of pneumococci after pneumococcal vaccination. Lancet 348:271–272

    Article  CAS  PubMed  Google Scholar 

  26. Obaro SK, Monteil MA, Henderson DC (1996) The pneumococcal problem. BMJ 312:1521–1525

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Podbielski A, Melzer B, Lütticken R (1991) Application of the polymerase chain reaction to study the M protein(−like) gene family in beta-hemolytic streptococci. Med Microbiol Immunol 180:213–227

    Article  CAS  PubMed  Google Scholar 

  28. Pumarola F, Mares J, Losada I, Minguella I, Moraga F, Tarrago D, Aguilera U, Casanovas JM, Gadea G, Trias E, Cenoz S, Sistiaga A, Garcia-Corbeira P, Pircon JY, Marano C, Hausdorff WP (2013) Microbiology of bacteria causing recurrent acute otitis media (AOM) and AOM treatment failure in young children in Spain: shifting pathogens in the post-pneumococcal conjugate vaccination era. Int J Pediatr Otorhinolaryngol 77:1231–1236

    Article  PubMed  Google Scholar 

  29. Qureishi A, Lee Y, Belfield K, Birchall JP, Daniel M (2014) Update on otitis media—prevention and treatment. Infect Drug Resist 7:15–24

    PubMed Central  PubMed  Google Scholar 

  30. Segal N, Givon-Lavi N, Leibovitz E, Yagupsky P, Leiberman A, Dagan R (2005) Acute otitis media caused by Streptococcus pyogenes in children. Clin Infect Dis 41:35–41

    Article  PubMed  Google Scholar 

  31. Stamboulidis K, Chatzaki D, Poulakou G, Ioannidou S, Lebessi E, Katsarolis I, Sypsa V, Tsakanikos M, Kafetzis D, Tsolia MN (2011) The impact of the heptavalent pneumococcal conjugate vaccine on the epidemiology of acute otitis media complicated by otorrhea. Pediatr Infect Dis J 30:551–555

    Article  PubMed  Google Scholar 

  32. van der Linden M, Reinert RR (2010) Serotype distribution in pneumococcal acute otitis media with ruptured tympanic membrane or sepsis in Germany. Eur J Clin Microbiol Infect Dis 29:749–754

    Article  PubMed  Google Scholar 

  33. Wald ER, Mason EO Jr, Bradley JS, Barson WJ, Kaplan SL (2001) Acute otitis media caused by Streptococcus pneumoniae in children’s hospitals between 1994 and 1997. The US Pediatric Multicenter Pneumococcal Surveillance Group. Pediatr Infect Dis J 20:34–39

    Article  CAS  PubMed  Google Scholar 

  34. Zhou F, Shefer A, Kong Y, Nuorti JP (2008) Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997–2004. Pediatrics 121:253–260

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Stephanie Perniciaro for assistance with statistical calculations and critically reading the manuscript and improving the English language. This study was financed by Pfizer Pharma GmbH Germany. We sincerely thank all actively participating study sites.

Conflict of interest

ML, MR, AB, and DA have been members of advisory boards of Pfizer Pharma GmbH Germany.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mark van der Linden.

Additional information

Communicated by Peter de Winter

Author’s summary

This study examines the bacteriology of middle ear fluids and nasopharyngeal carriage of children with spontaneously perforated AOM, thus providing surveillance data on pneumococcal disease and carriage in the era of routine pneumococcal vaccination in Germany.

Following universal PCV7 immunization, a clear epidemiological impact of pneumococcal conjugate vaccination was observed, as PCV7 serotypes have almost disappeared among AOM. Among the remaining serotypes, 3 and 19A are the most prevalent, indicating the added value of higher-valent pneumococcal conjugate vaccination. Concerning carriage, the percentage of children carrying pneumococci has not changed. However, the serotype distribution of carriage has strongly shifted toward non-PCV7 serotypes, showing that vaccination has the ability to replace serotypes common in AOM with ones that are probably less harmful. This might particularly be the case after the effects of PCV13 vaccination on AOM become visible in the next study years.

Mark van der Linden and Matthias Imöhl contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

van der Linden, M., Imöhl, M., Busse, A. et al. Bacterial spectrum of spontaneously ruptured otitis media in the era of pneumococcal conjugate vaccination in Germany. Eur J Pediatr 174, 355–364 (2015). https://doi.org/10.1007/s00431-014-2409-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-014-2409-0

Keywords

Navigation